Long-term prognosis of clinical symptoms and health-related quality of life in microscopic colitis: A case-control study

Alimentary Pharmacology and Therapeutics

Volumn 39, Issue 9, 2014, Pages 963-972

  Nyhlin, N ^a,b   Wickbom, A ^a,b   Montgomery, S M ^a,b,c   Tysk, C ^a,b   Bohr, J ^a,b  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; ANALGESIC AGENT; BUDESONIDE; COLESTYRAMINE; LOPERAMIDE;

ABDOMINAL PAIN; ADULT; AGE DISTRIBUTION; AGED; ARTHRALGIA; ARTICLE; CASE CONTROL STUDY; COLLAGENOUS COLITIS; COMPARATIVE STUDY; CONTROLLED STUDY; DEFECATION DISORDER; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; FATIGUE; FECES INCONTINENCE; FEMALE; GENERAL ASPECTS OF DISEASE; HUMAN; LYMPHOCYTIC COLITIS; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NOCTURNAL DEFECATION; OUTCOME ASSESSMENT; PATIENT WORRY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; REMISSION; SHORT HEALTH SCALE; SOCIAL STATUS; SYMPTOM; SYMPTOM BURDEN; WELLBEING;

ABDOMINAL PAIN; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLITIS, COLLAGENOUS; COLITIS, LYMPHOCYTIC; DIARRHEA; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; TIME FACTORS;

EID: 84898601507     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12685     Document Type: Article

References (52)

1. Jaskiewicz K, Rzepko R, Adrych K, Smoczynski M,. Microscopic colitis in routine colonoscopies. Dig Dis Sci 2006; 51: 241-4.
2. Lasson A, Kilander A, Stotzer PO,. Diagnostic yield of colonoscopy based on symptoms. Scand J Gastroenterol 2008; 43: 356-62. (Pubitemid 351238357)
3. Olesen M, Eriksson S, Bohr J, Jarnerot G, Tysk C,. Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998. Gut 2004; 53: 346-50. (Pubitemid 38241327)
4. Tysk C, Bohr J, Nyhlin N, Wickbom A, Eriksson S,. Diagnosis and management of microscopic colitis. World J Gastroenterol 2008; 14: 7280-8.
5. Yen EF, Pardi DS,. Review article: microscopic colitis-lymphocytic, collagenous and 'mast cell' colitis. Aliment Pharmacol Ther 2011; 34: 21-32.
6. Pardi DS, Kelly CP,. Microscopic colitis. Gastroenterology 2011; 140: 1155-65.
7. Gentile NM, Khanna S, Loftus EV Jr, et al,. The Epidemiology of Microscopic Colitis in Olmsted County from 2002 to 2010: a Population-based Study. Clin Gastroenterol Hepatol 2013; doi: 10.1016/j.cgh.2013.09.066 [Epub ahead of print].
8. Bohr J, Tysk C, Eriksson S, Abrahamsson H, Järnerot G,. Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut 1996; 39: 846-51. (Pubitemid 27049088)
9. Olesen M, Eriksson S, Bohr J, Jarnerot G, Tysk C,. Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut 2004; 53: 536-41. (Pubitemid 38372978)
10. Hjortswang H, Tysk C, Bohr J, et al,. Defining clinical criteria for clinical remission and disease activity in collagenous colitis. Inflamm Bowel Dis 2009; 15: 1875-81.
11. Hjortswang H, Tysk C, Bohr J, et al,. Health-related quality of life is impaired in active collagenous colitis. Dig Liver Dis 2011; 43: 102-9.
12. Madisch A, Heymer P, Voss C, et al,. Oral budesonide therapy improves quality of life in patients with collagenous colitis. Int J Colorectal Dis 2005; 20: 312-6. (Pubitemid 40909227)
13. Münch A, Aust D, Bohr J, et al,. Microscopic colitis: current status, present and future challenges: statements of the European Microscopic Colitis Group. J Crohns Colitis 2012; 6: 932-45.
14. Bonner GF, Petras RE, Cheong DM, Grewal ID, Breno S, Ruderman WB,. Short- and long-term follow-up of treatment for lymphocytic and collagenous colitis. Inflamm Bowel Dis 2000; 6: 85-91.
15. Fernandez-Banares F, Salas A, Esteve M, Espinos J, Forne M, Viver JM,. Collagenous and lymphocytic colitis. Evaluation of clinical and histological features, response to treatment, and long-term follow-up. Am J Gastroenterol 2003; 98: 340-7. (Pubitemid 36232383)
16. Jobse P, Flens MJ, Loffeld RJ,. Collagenous colitis: description of a single centre series of 83 patients. Eur J Intern Med 2009; 20: 499-502.
17. Madisch A, Miehlke S, Lindner M, Bethke B, Stolte M,. Clinical course of collagenous colitis over a period of 10 years. Z Gastroenterol 2006; 44: 971-4. (Pubitemid 44510551)
18. Mullhaupt B, Guller U, Anabitarte M, Guller R, Fried M,. Lymphocytic colitis: clinical presentation and long term course. Gut 1998; 43: 629-33. (Pubitemid 28520095)
19. Pardi DS, Ramnath VR, Loftus EV Jr, Tremaine WJ, Sandborn WJ,. Lymphocytic colitis: clinical features, treatment, and outcomes. Am J Gastroenterol 2002; 97: 2829-33. (Pubitemid 35265435)
20. Baert F, Wouters K, D'Haens G, et al,. Lymphocytic colitis: a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitis. Gut 1999; 45: 375-81. (Pubitemid 29400713)
21. Calabrese C, Gionchetti P, Liguori G, et al,. Clinical course of microscopic colitis in a single-center cohort study. J Crohns Colitis 2011; 5: 218-21.
22. Goff JS, Barnett JL, Pelke T, Appelman HD,. Collagenous colitis: histopathology and clinical course. Am J Gastroenterol 1997; 92: 57-60. (Pubitemid 27027029)
23. Sveinsson OA, Orvar KB, Birgisson S, Agnarsdottir M, Jonasson JG,. Clinical features of microscopic colitis in a nation-wide follow-up study in Iceland. Scand J Gastroenterol 2008; 43: 955-60.
24. Baert F, Schmit A, D'Haens G, et al,. Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology 2002; 122: 20-5. (Pubitemid 34049190)
25. Bonderup OK, Hansen JB, Birket-Smith L, Vestergaard V, Teglbjaerg PS, Fallingborg J,. Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis. Gut 2003; 52: 248-51. (Pubitemid 36115067)
26. Miehlke S, Heymer P, Bethke B, et al,. Budesonide treatment for collagenous colitis: a randomized, double- blind, placebo-controlled, multicenter trial. Gastroenterology 2002; 123: 978-84.
27. Miehlke S, Madisch A, Karimi D, et al,. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. Gastroenterology 2009; 136: 2092-100.
28. Bonderup OK, Hansen JB, Teglbjaerg PS, Christensen LA, Fallingborg JF,. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial. Gut 2009; 58: 68-72.
29. Hjortswang H, Jarnerot G, Curman B, et al,. The Short Health Scale: a valid measure of subjective health in ulcerative colitis. Scand J Gastroenterol 2006; 41: 1196-203. (Pubitemid 44451683)
30. Stjernman H, Granno C, Jarnerot G, et al,. Short health scale: a valid, reliable, and responsive instrument for subjective health assessment in Crohn's disease. Inflamm Bowel Dis 2008; 14: 47-52. (Pubitemid 351196868)
31. Wickbom A, Bohr J, Eriksson S, Udumyan R, Nyhlin N, Tysk C,. Stable incidence of collagenous colitis and lymphocytic colitis in Örebro, Sweden, 1999-2008: a continuous epidemiological study. Inflamm Bowel Dis 2013; 19: 2387-93.
32. Shaz BH, Reddy SI, Ayata G, et al,. Sequential clinical and histopathological changes in collagenous and lymphocytic colitis over time. Mod Pathol 2004; 17: 395-401. (Pubitemid 41646593)
33. Lee E, Schiller LR, Vendrell D, Santa Ana CA, Fordtran JS,. Subepithelial collagen table thickness in colon specimens from patients with microscopic colitis and collagenous colitis. Gastroenterology 1992; 103: 1790-6.
34. Abdo A, Raboud J, Freeman HJ, et al,. Clinical and histological predictors of response to medical therapy in collagenous colitis. Am J Gastroenterol 2002; 97: 1164-8. (Pubitemid 34478116)
35. Limsui D, Pardi DS, Camilleri M, et al,. Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis 2007; 13: 175-81. (Pubitemid 46806226)
36. Madisch A, Bethke B, Stolte M, Miehlke S,. Is there an association of microscopic colitis and irritable bowel syndrome-a subgroup analysis of placebo-controlled trials. World J Gastroenterol 2005; 11: 6409. (Pubitemid 43136873)
37. Abboud R, Pardi DS, Tremaine WJ, Kammer PP, Sandborn WJ, Loftus EV Jr,. Symptomatic overlap between microscopic colitis and irritable bowel syndrome: a Prospective Study. Inflamm Bowel Dis 2013; 19: 550-3.
38. Martinez C, Gonzalez-Castro A, Vicario M, Santos J,. Cellular and molecular basis of intestinal barrier dysfunction in the irritable bowel syndrome. Gut Liver 2012; 6: 305-15.
39. Spiller R, Lam C,. The shifting interface between IBS and IBD. Curr Opin Pharmacol 2011; 11: 586-92.
40. Spiller R, Lam C,. An update on post-infectious irritable bowel syndrome: role of genetics, immune activation, serotonin and altered microbiome. J Neurogastroenterol Motil 2012; 18: 258-68.
41. Bryant DA, Mintz ED, Puhr ND, Griffin PM, Petras RE,. Colonic epithelial lymphocytosis associated with an epidemic of chronic diarrhea. Am J Surg Pathol 1996; 20: 1102-9.
42. Halpin SJ, Ford AC,. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 2012; 107: 1474-82.
43. Jonefjall B, Strid H, Ohman L, Svedlund J, Bergstedt A, Simren M,. Characterization of IBS-like symptoms in patients with ulcerative colitis in clinical remission. Neurogastroenterol Motil 2013; 25: 756-e578.
44. Keohane J, O'Mahony C, O'Mahony L, O'Mahony S, Quigley EM, Shanahan F,. Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation? Am J Gastroenterol 2010; 105: 1789-94.
45. Vivinus-Nebot M, Frin-Mathy G, Bzioueche H, et al,. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Gut 2013; doi: 10.1136/gutjnl-2012-304066 [Epub ahead of print].
46. Grover M, Herfarth H, Drossman DA,. The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome. Clin Gastroenterol Hepatol 2009; 7: 48-53.
47. Long MD, Drossman DA,. Inflammatory bowel disease, irritable bowel syndrome, or what?: a challenge to the functional-organic dichotomy. Am J Gastroenterol 2010; 105: 1796-8.
48. Beaugerie L, Pardi DS,. Review article: drug-induced microscopic colitis-proposal for a scoring system and review of the literature. Aliment Pharmacol Ther 2005; 22: 277-84. (Pubitemid 41207456)
49. Fernandez-Banares F, de Sousa MR, Salas A, et al,. Epidemiological risk factors in microscopic colitis: a prospective case-control study. Inflamm Bowel Dis 2013; 19: 411-7.
50. Nyhlin N, Bohr J, Eriksson S, Tysk C,. Systematic review: microscopic colitis. Aliment Pharmacol Ther 2006; 23: 1525-34. (Pubitemid 43727459)
51. Rasmussen MA, Munck LK,. Systematic review: are lymphocytic colitis and collagenous colitis two subtypes of the same disease-microscopic colitis? Aliment Pharmacol Ther 2012; 36: 79-90.
52. Fernandez-Banares F, Gisbert JP,. Letter: are lymphocytic colitis and collagenous colitis really the same disease? Aliment Pharmacol Ther 2012; 36: 606.